Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




EMR-Based Tool Predicts Graft Failure After Kidney Transplant

By HospiMedica International staff writers
Posted on 12 Dec 2025

Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. More...

Although a successful transplant is expected to last about a decade, nearly one in four kidney grafts fail within five years, often without early warning signs. Clinicians currently lack reliable ways to identify which patients are most at risk of losing a transplanted kidney. A new study now shows that routinely collected kidney function data can be used to dynamically predict graft failure risk years before it happens.

Researchers at Johns Hopkins Medicine (Baltimore, MD, USA) have developed an electronic medical record (EMR)–based prediction model that continuously updates a patient’s risk of graft failure using changes in estimated glomerular filtration rate, a standard blood test that reflects how well a transplanted kidney is functioning. The approach allows risk to be recalculated every time new lab results become available.

The model was built using data from 1,114 deceased-donor kidney transplant recipients and validated across multiple large datasets, including national transplant registries and real-world hospital records. Investigators analyzed repeated kidney function measurements over time and linked these trajectories to graft failure, defined as a return to dialysis or the need for a second transplant within three years.

The results, published in the Clinical Journal of the American Society of Nephrology, showed that the model could effectively distinguish high-risk from low-risk patients. Predictive accuracy reached 0.70 just three months after transplant and improved to 0.90 by 30 months, demonstrating strong performance well before clinical failure occurred.

By identifying patients at elevated risk, the tool could support earlier interventions such as closer monitoring, adjustments to immunosuppressive therapy, and counseling about future transplant needs. At the same time, patients at low risk could safely transition back to routine nephrology care closer to home, freeing transplant center resources.

Researchers now plan to test the model in everyday clinical practice and expand it by incorporating additional health data, including clinical events and other laboratory markers. These efforts aim to further improve early detection of graft injury and long-term transplant outcomes.

“The results from this study can be readily implemented at transplant centers to streamline care of kidney transplant recipients by providing updated risk predictions as new data become available,” said Chirag Parikh, MD, PhD, the study’s senior author. “There could also be future downstream models developed to predict other infections and immunologic complications.”

Related Links:
Johns Hopkins Medicine


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.